Ah, missed that. Great, hopefully a good sign.
Printable View
Good to see one of PEB’s greatest supporters still buying
They deserve to be richly rewarded one day for their loyalty
Must be missing Dave though……apparently in the past when the share price was falling they’d ring Dave.and say ‘Dave, put out another announcement. Doesn’t matter whether its a regurgitation of old news but just make positive’
Hopefully momentum is gaining in the background and we hear something from Dr Peter Meintjes soon enough. Do we know which date to expect an update?
In my experience Harbour and Jarden are fairly savvy fund manager investors. They get a leg in by being able to talk to company execs who have a handle on progress. Joe Blow does not get that opportunity.
I cannot imagine that Harbour are buying on spec. Thats not their playbook. That movement over a short time horizon means something. The market is too thin to be playing the pump and dump game IMO, so this looks to me like a longer term hold for them.
Either that or they are trying to make their results look better for Y/E 31st March 2022
One good story David came out with several years ago was that had a melanoma test ready to go .... was going to distinguish the real bad melanomas as David said its the real bad bad ones thta kill people
Wonder what happened
It's still in their pipeline:
https://www.pacificedgedx.com/products/pipeline/
Thats true but why increase their shareholding if they are not convinced that there is value going forward. Doesn't really make sense unless they are propping the SP up to look better at financial Y/E? Unlikely at this point in the month unless they think that by increasing their shareholding, it hypes the speculation and encourages the punters to invest . Bit cynical but the market is full of dirty little tricks
Yeah they probably think there is value in the share but who is to say they are right. If we shareholders have all the info available than from my point of view any decision to buy this share is purely speculation that there will be significant adoption of Cx bladder which we haven’t seen to date. Unless the Instos have inside info (a no no of course) or they have done additional research - polling the opinions of urologists or understanding the position of AUA better then they are taking a punt like the rest of us.
one thing for sure is they haven’t been reading psychic’s posts.
There's always a degree of uncertainty with a business like this - and whether the multiple moves they make in the market will pay off in the long-run. Whilst sales is undoubtedly a process, there is always an element of being in the right place at the right time (and engaging with the right people). At the very least, I would like to see a greater adoption by the DHB's in the NZ market.
I wouldn't be holding my breath waiting for a major SP-moving announcement in the upcoming publication. It will only contain items of general interest about PEB's activities, tell us about the new CEO and his plans and continue to express hope for future success.
A major breakthrough of some kind will be announced when - or if - it happens.
PEB does not seem very eager to get their March update announcement out do they. Waiting for something more substantial to hopefully be able to show share holders what benefits have been made from their last Cap Raise. Or hesitant because nothing positive enough to provide support to SP and confidence in existing share holders. Might see SP slide back to recent lows in the 0.8's if nothing follows soon.
If nothing else, at the very least they should be able to report a bit of extra interest income on the $100 million in the bank from the CR.
The newsletter delay must be due to the new CEO diving deep into the files and checking previous releases to make sure he presents the same previous info in a different way. I'm far from optimistic we will receive any positive surprises this month.
Be good to have the silence broken though to confirm the PEB team hasn't run away to Sth America with all our money!
Hope Peter Meintjes in going through all Daves papers come to the conclusion that most of what Dave said was well a load of the proverbial and saying to himself 'what have got myself into, should have done more due diligence'
Whatever I like how he puts things on linkedin about his past ..... taken businesses from startup through the "Valley of Death" to profitability...... and excited how he combine advances in biochemistry, therapeutics, software and informatics with elegant business models. ....cooleh
Surprising the SP seems to be holding for now at 0.90, hopefuls maybe. Lack of update or just the same ol regurgitated news will likely see some larger investors back out until any more solid progress is made, especially seeing DD is no longer aboard. If the funds from Cap Raise have been spent on salaries and targeted US development but there isn't anything substantial to report from it then larger investors that dissipated in the Cap Raise at 1.25/1.35 might be inclined to cut their losses and wait for a more upbeat uptrend to buy back in. Current holders will be hopping for some very positive tangible reports on this update with new management and money in the bank. Pretty stable nerves to hold at this point with such long silence. Looking like they see resistance at 0.90. But if that breaks with just a few larger volume sells then things might be a bit dubious for the SP. Dropped a long way off 1.5 and with no DD to keep boosting positivity and SP look where its already gone 1.5 down to 0.9 after a large Cap Raise.
In June 2020 the shares were trading at 26 c so we cannot complain too much about the price now. The investors that bought in at the capital raise clearly must have thought the company had good prospects and really nothing has changed much since then. When prices slide people get scared and sell which adds to the momentum. I see that a lot on sharetrader - peoples views are governed by the direction of the market rather than the prospects of the company.